New Vice-chair Appointed to Commission on Human Medicines
News Jan 27, 2015
The CHM advises on matters relating to safety, quality and the efficacy of medicines as well as the collection of adverse drug reactions.
Dr Angela Thomas is a consultant paediatric haematologist at the Royal Hospital for Sick Children in Edinburgh, a fellow of the Royal College of Physicians in Edinburgh, a former President of the British Society for Haematology and has been on the CHM since 2005, where she chairs the Clinical Trials, Biologicals & Vaccines Expert Advisory Group.
She has also served as a member and chaired many scientific and medical committees in the UK and Europe.
Dr Angela Thomas said: “I am delighted to be taking up this new role. The Commission plays a vital role in the licensing of new medicines and in monitoring drug safety. I have found my time as a member of CHM tremendously rewarding and am looking forward to the challenges offered in my new role as vice-chair.”
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019
Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress
Oct 24 - Oct 26, 2019